Stock Splits
By The Online Investor Staff, updated Tue., May. 24, 9:04 AM
| This Slide: #8 of 25 |
Slide #8. Rockwell Medical, Inc. (NASDAQ:RMTI) — 1 for 11 Reverse Split
Announced:
5/12/2022
Stock Split:
1 for 11
Record Date:
5/12/2022
Pay Date:
5/13/2022
RMTI Optionable?:
Yes
Rockwell Medical is a commercial-stage, biopharmaceutical company developing and commercializing its parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC). Co. is also a supplier of hemodialysis concentrate products to kidney dialysis clinics in the U.S. Co. has two therapies, Triferic and Triferic AVNU, which are developed from its FPC platform. Co. markets both products to kidney dialysis centers for their patients receiving dialysis. Co. has filed an Investigational New Drug Application to conduct a Phase II trial for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting. 
RMTI Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the RMTI Page at The Online Investor (in a new window) »
 Free RMTI Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 74th percentile
(ranked higher than approx. 74% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
